The same approach that identified SFN as a tumour suppressor in HER2-induced tumorigenesis was also applied to the systematic exploration of recurrent CNAs in other models, yielding a list of candidate genes that may underlie these driver-specific events. This evidence concerns the gene ERBB2 and neoplasm.